FWA
GSK icon

Flagship Wealth Advisors’s GSK GSK Stock Holding History

Flagship Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.7K Buy
1,140
+18
+2% +$952 0.01% 254
2026
Q1 		$43.1K Sell
1,122
-10
-0.9% -$542 0.02% 201
2025
Q4 		$55.5K Buy
1,132
+5
+0.4% +$233 0.02% 210
2025
Q3 		$48.7K Buy
1,127
+5
+0.4% +$195 0.02% 221
2025
Q2 		$43.1K Buy
1,122
+5
+0.4% +$191 0.02% 218
2025
Q1 		$43.3K Buy
1,117
+5
+0.4% +$183 0.02% 213
2024
Q4 		$37.6K Buy
+1,112
New +$40K 0.02% 208

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Flagship Wealth Advisors's GSK Position: Q2 2026 in Review

Flagship Wealth Advisors increased its GSK (GSK) stake by 1.6% in Q2 2026, buying an estimated $952 and bringing the position to 1,140 shares worth $59.7K. The position accounts for 0.01% of the portfolio, ranked #254.

Flagship Wealth Advisors first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Flagship Wealth Advisors held 1,140 shares of GSK worth $59.7K as of Q2 2026.
  • Flagship Wealth Advisors bought 18 GSK shares in Q2 2026, an estimated $952.
  • GSK made up 0.01% of Flagship Wealth Advisors's portfolio in Q2 2026, its #254 holding.
  • Flagship Wealth Advisors first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Flagship Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.